Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. SC 13D/A Stake Beneficial Ownership Report
  2. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. SC 13D/A Stake Beneficial Ownership Report
  9. SC 13D/A Stake Beneficial Ownership Report
  10. UPLOAD Other SEC-generated Letter
  11. 10-Q Report Quarterly Report
  12. 4 Insider Changes in Ownership
  13. SC 13D/A Stake Beneficial Ownership Report
  14. S-3 Offering Registration Statement
  15. EFFECT Other Notice of Effectiveness
  16. DEFA14A Proxy Proxy Materials
  17. DEF 14A Proxy Proxy Statement
  18. POS AM Other Post-effective Amendment for Registration Statement
  19. PRE 14A Proxy Proxy Statement (Preliminary)
  20. 4 Insider Changes in Ownership

Page 23 of 72 · 1,429 filings